Please login to the form below

Not currently logged in
Email:
Password:

SO Patient

This page shows the latest SO Patient news and features for those working in and with pharma, biotech and healthcare.

Roche’s Actemra fails in late-stage severe COVID-19 study

Roche’s Actemra fails in late-stage severe COVID-19 study

The theory behind testing Actemra in this patient setting is based on the idea that its anti-inflammatory properties could counteract the overactive inflammatory responses observed in the lungs of critically ... Although this class of drug has failed in

Latest news

More from news
Approximately 1 fully matching, plus 123 partially matching documents found.

Latest Intelligence

  • Patient-centred drug development: how far have we come and what’s next? Patient-centred drug development: how far have we come and what’s next?

    By Jo Fearnhead-Wymbs. Putting the patient at the centre of clinical development’. ... This is also why, as mentioned above, early integration of patient perspectives is so beneficial – it allows us to shape our services from the ground up, in a

  • Understanding the ‘real world’ starts and ends with the patient Understanding the ‘real world’ starts and ends with the patient

    The design and delivery of every PRO study must be developed with a view to enhance each patient’s experience, so we. ... What lies ahead? Healthcare systems and how healthcare is delivered will continually evolve, so how do we make sure that the

  • Recruiting patients for real-world studies – the power of a digital campaign Recruiting patients for real-world studies – the power of a digital campaign

    So, how can study sponsors reach such a large body of prospective study participants? ... If so, the recruited sample should reflect the age and gender of the patient population in the therapy area.

  • Empowering patients empowers results Empowering patients empowers results

    Decentralised clinical trials that can take place from a patient’s home are clearly gaining ground. ... As patient convenience improves, so does compliance and adherence to protocol, which leads to more accurate results and swifter development of new

  • Digitising healthcare Digitising healthcare

    efficiency. In turn, this reduces patient waiting time and enables smart prioritisation for those who require faster care. ... After all, patient care comes first, so regulations and processes must be in place to keep standards high across all settings.

More from intelligence
Approximately 0 fully matching, plus 57 partially matching documents found.

Latest appointments

  • New faces at Synergy Vision, Makara Health and JPA Health New faces at Synergy Vision, Makara Health and JPA Health

    I’m passionate about delivering projects that challenge the status quo and improve patient outcomes, so this is an incredibly exciting time to be at the forefront of medical communications with ... regional health communications campaigns. In her new

  • Ferring appoints executive VP and chief medical officer Ferring appoints executive VP and chief medical officer

    Michel Pettigrew, president of the executive board and chief operating officer, Ferring Pharmaceuticals, said: “Making the industry more patient-centric has always been a top priory for Professor Dugi, and this ... is perfectly aligned with our

  • Sanofi appoints ‘chief patient officer’ Sanofi appoints ‘chief patient officer’

    The company explained that Dr Beal will be tasked with elevating the 'perspective of the patient within Sanofi so the company's future healthcare offerings can better incorporate the unique priorities ... the patient perspective advances our approach to

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 77 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...